Mesoblast (MESO) Share-based Compensation (2016 - 2025)

Mesoblast's (MESO) quarterly Share-based Compensation came in at $15.2 million in Q2 2025, up 591.21% year-on-year from $2.2 million in Q2 2024, and up 591.21% quarter-over-quarter from $2.2 million in Q2 2024.

Mesoblast (MESO) Share-based Compensation (2016 - 2025) Analysis & Trends

Mesoblast has disclosed Share-based Compensation across 10 years of filings, most recently posting $15.2 million for Q2 2025.

  • Share-based Compensation for Q2 2025 came in at $15.2 million, up 591.21% year-over-year; the trailing twelve-month figure through Jun 2025 was $13.9 million (up 2836.15% YoY), and the FY2025 annual result was $15.2 million, up 591.21% from the prior year.
  • Share-based Compensation came in at $15.2 million for Q2 2025 at Mesoblast, up from $2.2 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $15.2 million in Q2 2025 to a low of -$6.5 million in Q1 2022.
  • The 5-year median for Share-based Compensation is $2.0 million (2022), against an average of $3.2 million.
  • Across the five-year window, Share-based Compensation tumbled 162.35% in 2022 and soared 591.21% in 2025, its largest moves.
  • Mesoblast's Share-based Compensation stood at $2.6 million in 2021, then plunged by 31.26% to $1.8 million in 2022, then changed by 0.0% to $1.8 million in 2023, then rose by 24.93% to $2.2 million in 2024, then jumped by 591.21% to $15.2 million in 2025.
  • The last three Share-based Compensation figures came in at $15.2 million (Q2 2025), $2.2 million (Q2 2024), and $1.8 million (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 305,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 166.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - 26.47 Mn
10 Mesoblast 21.68 Bn 21.55 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 15.17 Mn
Jun 30, 2025 15.17 Mn
Jun 30, 2024 2.20 Mn
Jun 30, 2024 2.20 Mn
Jun 30, 2023 1.76 Mn
Jun 30, 2023 1.76 Mn
Mar 31, 2023 -5.24 Mn
Mar 31, 2023 -5.24 Mn
Dec 31, 2022 1.76 Mn
Dec 31, 2022 1.76 Mn
Sep 30, 2022 350,000.00
Sep 30, 2022 350,000.00
Jun 30, 2022 4.45 Mn
Jun 30, 2022 4.45 Mn
Mar 31, 2022 -6.51 Mn
Mar 31, 2022 -6.51 Mn
Dec 31, 2021 2.56 Mn
Dec 31, 2021 2.56 Mn
Sep 30, 2021 1.08 Mn
Sep 30, 2021 1.08 Mn